CombiMatrix targets avian flu markets in Asia with Cold Spring Biotech deal:
This article was originally published in Clinica
Executive Summary
CombiMatrix, a division of Acacia Research, has appointed Cold Spring Biotech as non-exclusive distributor of its range of CustomArrays and CatalogArrays in China, Taiwan and Hong Kong. The agreement gives CombiMatrix entry into the fast-growing Asian markets where tests such as the company's Influenza A research microarrays can be used in fighting the spread of influenza H5N1, also known as avian flu.